中华实用儿科临床杂志
中華實用兒科臨床雜誌
중화실용인과림상잡지
Journal of Applied Clinical Pediatrics
2014年
5期
354-356
,共3页
汪力%祁海杰%谢艳丽%王涛%龚立%皮名安
汪力%祁海傑%謝豔麗%王濤%龔立%皮名安
왕력%기해걸%사염려%왕도%공립%피명안
生长抑素%乳糜胸%心脏病,先天性%胸导管结扎%儿童
生長抑素%乳糜胸%心髒病,先天性%胸導管結扎%兒童
생장억소%유미흉%심장병,선천성%흉도관결찰%인동
Somatostatin%Chylothorax%Congenital heart disease%Thoracic duct ligation%Child
目的 研究生长抑素在儿童先天性心脏病术后乳糜胸保守治疗中的临床疗效.方法 回顾性分析2003年1月至2012年12月武汉市儿童医院收治的先天性心脏病术后并发乳糜胸的13例患儿临床资料,2009年前采用常规治疗(对照组,6例),2009年后采用生长抑素治疗(治疗组,7例),2组患儿年龄、体质量、术后发生乳糜胸时间等一般资料比较,差异均无统计学意义,乳糜胸诊断标准一致.分析比较2组病例治疗前、治疗中乳糜胸引量变化、治愈时间等指标.结果 对照组6例乳糜胸患儿中3例经保守治疗临床治愈,3例保守治疗无效(2例手术治疗痊愈,1例死亡).对照组乳糜胸引量在治疗后1周[(155.5±85.7) mL/d]及2周[(142.3 ±110.3) mL/d]较治疗前[(256.6±124.2) mL/d]减少(t=4.623、2.099,P=0.002、0.044).对照组乳糜胸引量治疗3周后[(139.4±113.4) mL/d]较治疗前无明显减少(t=1.745,P=0.07).治疗组6例保守治疗成功,1例手术后痊愈.治疗组乳糜胸引量在治疗后1周[(51.2±18.7) mL/d]及2周[(19.3 ±7.05)mL/d]较治疗前[(300.3 ±115.6) mL/d]明显减少(t=5.549、6.638,P=0.001、0.001).2组胸引量在治疗后1周、2周比较差异均有统计学意义(t=2.900、2.412,P=0.014、0.034).2组保守治愈病例术后痊愈时间[(32.8±1.8)d比(25.2±1.7)d]差异有统计学意义(=2.512,P=0.028).结论 生长抑素能促进婴幼儿术后乳糜胸恢复,在早期保守治疗中应积极使用.
目的 研究生長抑素在兒童先天性心髒病術後乳糜胸保守治療中的臨床療效.方法 迴顧性分析2003年1月至2012年12月武漢市兒童醫院收治的先天性心髒病術後併髮乳糜胸的13例患兒臨床資料,2009年前採用常規治療(對照組,6例),2009年後採用生長抑素治療(治療組,7例),2組患兒年齡、體質量、術後髮生乳糜胸時間等一般資料比較,差異均無統計學意義,乳糜胸診斷標準一緻.分析比較2組病例治療前、治療中乳糜胸引量變化、治愈時間等指標.結果 對照組6例乳糜胸患兒中3例經保守治療臨床治愈,3例保守治療無效(2例手術治療痊愈,1例死亡).對照組乳糜胸引量在治療後1週[(155.5±85.7) mL/d]及2週[(142.3 ±110.3) mL/d]較治療前[(256.6±124.2) mL/d]減少(t=4.623、2.099,P=0.002、0.044).對照組乳糜胸引量治療3週後[(139.4±113.4) mL/d]較治療前無明顯減少(t=1.745,P=0.07).治療組6例保守治療成功,1例手術後痊愈.治療組乳糜胸引量在治療後1週[(51.2±18.7) mL/d]及2週[(19.3 ±7.05)mL/d]較治療前[(300.3 ±115.6) mL/d]明顯減少(t=5.549、6.638,P=0.001、0.001).2組胸引量在治療後1週、2週比較差異均有統計學意義(t=2.900、2.412,P=0.014、0.034).2組保守治愈病例術後痊愈時間[(32.8±1.8)d比(25.2±1.7)d]差異有統計學意義(=2.512,P=0.028).結論 生長抑素能促進嬰幼兒術後乳糜胸恢複,在早期保守治療中應積極使用.
목적 연구생장억소재인동선천성심장병술후유미흉보수치료중적림상료효.방법 회고성분석2003년1월지2012년12월무한시인동의원수치적선천성심장병술후병발유미흉적13례환인림상자료,2009년전채용상규치료(대조조,6례),2009년후채용생장억소치료(치료조,7례),2조환인년령、체질량、술후발생유미흉시간등일반자료비교,차이균무통계학의의,유미흉진단표준일치.분석비교2조병례치료전、치료중유미흉인량변화、치유시간등지표.결과 대조조6례유미흉환인중3례경보수치료림상치유,3례보수치료무효(2례수술치료전유,1례사망).대조조유미흉인량재치료후1주[(155.5±85.7) mL/d]급2주[(142.3 ±110.3) mL/d]교치료전[(256.6±124.2) mL/d]감소(t=4.623、2.099,P=0.002、0.044).대조조유미흉인량치료3주후[(139.4±113.4) mL/d]교치료전무명현감소(t=1.745,P=0.07).치료조6례보수치료성공,1례수술후전유.치료조유미흉인량재치료후1주[(51.2±18.7) mL/d]급2주[(19.3 ±7.05)mL/d]교치료전[(300.3 ±115.6) mL/d]명현감소(t=5.549、6.638,P=0.001、0.001).2조흉인량재치료후1주、2주비교차이균유통계학의의(t=2.900、2.412,P=0.014、0.034).2조보수치유병례술후전유시간[(32.8±1.8)d비(25.2±1.7)d]차이유통계학의의(=2.512,P=0.028).결론 생장억소능촉진영유인술후유미흉회복,재조기보수치료중응적겁사용.
Objective To investigate the therapeutic efficacy of somatostatin on chylothorax after congenital heart disease surgery in children.Methods Retrospective analysis was performed in 13 postoperative chylothorax cases from Jan.2003 to Dec.2012,who were divided into control group (n =6) and treatment group (n =7),and there was no significant difference in age,weight,and time of occurrence between the 2 groups.The diagnosis standard for chylothorax was the same.The changes of chylous volume during the treatment were analyzed between 2 groups,and healing time and other data were analyzed too.Results Control group:clinical cure in 3 cases,conservative treatment failed in 3 cases(2 cases recovered after operation and 1 case died).The chyle volume of control group reduced obviously compared with post treatment from beginning [(256.6 ± 124.2) mL/d] to 1 week [(155.5 ± 85.7) mL/d] and 2 weeks [(142.3 ± 110.3) mL/d] later(t =4.623,2.099 ; P =0.002,0.044).But it did not reduce obviously in 3 weeks later[(139.4 ± 113.4) mL/d] (t =1.745,P =0.07).Treatment group:6 cases in treatment group were successful in recovery after conservative treatment and 1 case underwent operation.The chyle volume of treatment group reduced obviously compared with post treatment from beginning to 1 week [(51.2 ± 18.7) mL/d] and 2 weeks [(19.3 ± 7.05) mL/d] later (t =5.549,6.638 ;P =0.001,0.001).Compared with the control group,the difference between 2 groups in post treatment (1 week later,2 weeks hater) was of statistical significance (t =2.900,2.412 ; P =0.014,0.034).The healing time of conservative treatment in 2 groups (only for recovery) had obvious difference [(32.8 ± 1.8) d,(25.2 ± 1.7) d] (t =2.512,P =0.028).Conclusions The use of somatostatin can significantly promote the recovery of chylothorax in children,and it should be actively used in early conservative treatment.